Neuroimaging methods have considerably developed over the last decades and offer various noninvasive approaches for measuring cerebral metabolic fluxes connected to energy metabolism, including PET and magnetic resonance spectroscopy (MRS). Among these methods, 31 P MRS has the particularity and advantage to directly measure cerebral ATP synthesis without injection of labeled precursor. However, this approach is methodologically challenging, and further validation studies are required to establish 31 P MRS as a robust method to measure brain energy synthesis. In the present study, we performed a multimodal imaging study based on the combination of 3 neuroimaging techniques, which allowed us to obtain an integrated picture of brain energy metabolism and, at the same time, to validate the saturation transfer 31 P MRS method as a quantitative measurement of brain ATP synthesis. A total of 29 imaging sessions were conducted to measure glucose consumption (CMRglc), TCA cycle flux (VTCA), and the rate of ATP synthesis (VATP) in primate monkeys by using 18 F-FDG PET scan, indirect 13 C MRS, and saturation transfer 31 P MRS, respectively. These 3 complementary measurements were performed within the exact same area of the brain under identical physiological conditions, leading to: CMRglc ‫؍‬ 0.27 ؎ 0.07 mol⅐g ؊1 ⅐min ؊1 , VTCA ‫؍‬ 0.63 ؎ 0.12 mol⅐g ؊1 ⅐min ؊1 , and VATP ‫؍‬ 7.8 ؎ 2.3 mol⅐g ؊1 ⅐min ؊1 . The consistency of these 3 fluxes with literature and, more interestingly, one with each other, demonstrates the robustness of saturation transfer 31 P MRS for directly evaluating ATP synthesis in the living brain.
glycolysis ͉ TCA cycle ͉ oxidative phosphorylation ͉ NMR spectroscopy ͉ metabolic fluxes N umerous brain disorders, like neurodegenerative diseases, are associated with impairment in energy metabolism. This observation has been driving considerable technological developments in medical imaging, aiming at measuring brain energy metabolism. PET combined with 18 F-2-f luoro-2-deoxy-Dglucose ( 18 F-FDG) injection has been used in research on normal and pathological brain for Ϸ30 years (1-3). More recently, magnetic resonance spectroscopy (MRS) has brought new tools for imaging cerebral energy fluxes (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) .
However, methodological developments are still needed to answer the clinical need for earlier diagnosis and follow-up of neurodegenerative pathologies. Although PET detection of 18 F-FDG has proven efficient to map cerebral glucose consumption (CMRglc), this technique does not directly reflect energy storage and utilization that is mainly derived from glucose oxidation. Also, PET is unlikely to become widely accessible, due to its invasiveness and cost. However, magnetic resonance is of widespread use for anatomical imaging, and clinical scanners can be equipped for metabolic imaging at limited cost. Indeed, MRS has proven powerful to measure brain energy metabolism by detecting 13 C, 17 O, or 31 P nuclei, which only require dedicated radiofrequency components. Quantitative measurement of cerebral oxidative metabolism by 13 C (4-11) or 17 O (14-16) MRS has been demonstrated. However, these approaches require i.v. injection of expensive precursors followed by time-consuming acquisition. In contrast, 31 P MRS has the potential to measure the cerebral rate of ATP synthesis V ATP without any injection, using the magnetization transfer technique as originally demonstrated by Brown et al. (17) . Up to now, only 2 measurements of cerebral V ATP have been reported in rodents (12, 18) , and 1 in humans (13) . MRS-derived V ATP reported in these pioneer studies appeared consistent with literature values and coupled with brain activity over a large range of anesthesia (18) . However, MRS-derived V ATP may be contaminated by a nearequilibrium exchange reaction between inorganic phosphate (P i ) and ATP catalyzed by the glycolytic enzymes GAPDH and phosphoglycerate kinase (PGK). Such a contamination, leading to an overestimation of the NMR-detected V ATP, was inconsistently reported on yeast suspensions (19) , with a possible dependence on the growth medium. MRS-derived V ATP was also shown to be contaminated by glycolytic enzymes ex vivo on perfused peripheral organs (20, 21) , on rodent skeletal muscle (22) , and human skeletal muscle (23) . Given these elements, further studies are required to establish 31 P magnetization transfer as a reliable quantitative method for measuring the cerebral rate of energy synthesis V ATP . In this context, our purpose has been to validate the 31 P MRS measurement of brain V ATP , by comparing the rate of ATP synthesis measured in primates with CMRglc and TCA cycle rate (V TCA ) measured by PET and 13 C MRS, respectively. Under normal physiological conditions, glucose breakdown (through glycolysis and TCA cycle) is stoechiometry coupled to ATP synthesis, so that theoretical V ATP can be calculated from the measured CMRglc and V TCA , providing a direct way to validate MRS-measured V ATP .
Results show that CMRglc and V TCA measured in the primate brain are highly consistent, showing the expected 1:2 stoechiometry between glycolysis and TCA cycle (1 glucose giving rise to 2 pyruvate molecules). Also, the theoretical value of V ATP derived from CMRglc and V TCA is very close to that directly measured using 31 P MRS and magnetization transfer. These results demonstrate that 31 P MRS is a reliable method to measure brain ATP synthesis in vivo.
Results
High-resolution scout MRI of the monkey brain is presented on Fig. 1 , showing the 8-mL volume of interest (VOI) where the 3
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Freely available online through the PNAS open access option. 1 To whom correspondence should be addressed. E-mail: vincent.lebon@cea.fr. metabolic fluxes were measured. Anatomical landmarks on coronal, axial, and sagital images made it possible to reposition the VOI identically for all imaging sessions.
A typical 18 F-FDG PET image (axial view; acquisition time, 20 min) is presented on Fig. 2A . The corresponding 18 F time activity curve in the selected VOI and the experimental 18 F arterial time activity curve are plotted in Fig. 2B . Kinetic analysis of 18 F-FDG uptake produced an estimation of 18 F-FDG-6-P and 18 F-FDG contributions to total activity (Fig. 2B ), leading to CMRglc ϭ 0.27 Ϯ 0.07 mol⅐g Ϫ1 ⅐min Ϫ1 . Fig. 3A shows a stacked plot of difference 1 H-{ 13 C} spectra (averaged over the 8 13 C NMR sessions) acquired during an i.v. infusion of [U- 13 C 6 ] glucose. Corresponding 13 C-enrichment time courses of glutamate C3 and C4 are presented in Fig. 3B . The continuous lines represent the best fit to experimental data according to the metabolic model. This analysis leads to V TCA ϭ 0.63 Ϯ 0.12 mol⅐g Ϫ1 ⅐min Ϫ1 . The P i region of 31 P spectra acquired with ␥-ATP saturation for 4 different saturation times (0.5, 1.0, 1.5, and 2 s) is presented in Fig. 4A (averaged over the 15 31 P NMR sessions). It shows that P i amplitude is decreased while the saturation time is increased. Note that P i decrease on this figure is due to both saturation transfer effect and RF bleed over effect, the later explaining the decrease of resonances surrounding P i (mostly phosphodiesters and phosphomonoesters Ϸ3 and 7 ppm, respectively); 31 P spectra were corrected for RF bleed over by subtracting ␥-ATP saturated spectra from control spectra where saturation was applied symmetrically to ␥-ATP. Inversion-recovery experiments yielded a mean value of T1 mix ϭ 2.05 s. Consequently, the averaged P i attenuation vs. t sat was fitted fixing the following parameters: T1 mix ϭ 2.05 s, ϭ 60°, TR ϭ 2.95 s. The best fit is shown on Fig. 4B ). The small differences between these values and CMRglc and V TCA measured in this study could be explained by differences in VOI position, and consequently by different contributions of gray and white matter to the detected fluxes: in our study, gray matter accounts for 58 Ϯ 2% of the detected brain tissue, as measured on high resolution T1-weighted images (data not shown). This percentage is likely to be higher than gray matter content in the voxel detected by Boumezbeur et al. (30) , which was located deeper in the brain and included significantly less cortical areas. Given the strong de- pendence of glucose metabolism on gray matter content (7), a slight difference in gray matter fraction might explain our higher CMRglc and V TCA values (0.27 and 0.63 mol⅐g Ϫ1 ⅐min Ϫ1 , respectively). PET measurements of CMRglc have been reported recently in the monkey brain, and found to be close to 0.3 mol⅐g Ϫ1 ⅐min Ϫ1 in brain areas similar to our VOI (31). This value is very close to our measurement (0.27 mol⅐g Ϫ1 ⅐min Ϫ1 ). Our V TCA values (0.63 Ϯ 0.12 mol⅐g Ϫ1 ⅐min Ϫ1 ) are in agreement with reported human values that range from 0.57 to 0.77 mol⅐g Ϫ1 ⅐min Ϫ1 (6, 8, 9, 11) . The measurement of V ATP reported in this article is, to our knowledge, the first one performed in the monkey brain. Compared with the only one reported measurement of cerebral V ATP that was performed in humans (13) , the V ATP value reported in this study appears slightly lower (7.8 Ϯ 2.3 mol⅐g Ϫ1 ⅐min Ϫ1 vs. 12.1 Ϯ 2.8 mol⅐g Ϫ1 ⅐min Ϫ1 ). However, the SD ranges of both measurements overlap so that no significant difference can be inferred.
Consistency Between CMRglc and VTCA. In this study, a [V TCA / CMRglc] ratio of 2.25 is measured, reflecting the metabolic coupling between glycolysis and TCA cycle. Considering that glucose is the unique metabolic fuel under normal physiological conditions, a [V TCA /CMRglc] ratio of 2 would be expected, because glycolysis produces 2 molecules of pyruvate per glucose. The measured [V TCA /CMRglc] ratio is 12.5% higher than the expected theoretical value, leaving room for a possible contribution of fatty acids to the TCA cycle (CMR FA ϭ V TCA Ϫ 2 CMRglc). However, given the fact that the SD on each flux (V TCA and CMRglc) is Ϸ15%, the [V TCA /CMRglc] ratio is not high enough to claim a significant contribution of the fatty acid pathway. The 12.5% excess over theoretical ratio could be partly ascribed to experimental inaccuracy.
Potential Effect of Glycemia on the Measured Fluxes. Blood glucose was measured during the course of PET and 13 C-NMR sessions. Glycemia measured at the beginning of 13 C-NMR sessions (before 13 C glucose injection) and during the course of PET measurements were all in the 3-5 mmol⅐L Ϫ1 normoglycemic range; 13 C measurement of V TCA was performed under hyperglycemia (9-15 mmol⅐L Ϫ1 in our study), because a several fold increase in glycemia is required to bring 13 C enrichment of blood glucose up to Ͼ50%. In this context, one may wonder whether CMRglc and V TCA are affected by blood glucose content. CMRglc dependence on glycemia has been studied by several groups, who concluded that brain glucose uptake is not affected by acute hyperglycemia. Evidence for this result was demonstrated in rodents as well as in humans (34, 35) . Unfortunately, V TCA dependence on glycemia has not been studied as thoroughly as CMRglc, due to the lack of method (besides 13 C NMR) for noninvasive measurement of the TCA cycle flux. It must be kept in mind that V TCA measured using 13 C-labeled glucose includes the contributions of all possible substrates of acetylCoA oxidation. Therefore, NMR-measured V TCA is directly coupled to CMRO 2 (14) , as shown ex vivo on brain slices (36) . Since several studies have reported that CMRO 2 remains independent from glycemia in mammals (37, 38) , the absence of glycemic dependence can be reasonably extended to V TCA . Note that glycemia was not measured during 31 P-NMR sessions, because V ATP measurement does not require vascular catheterisation. Due to the similarity of experimental conditions with PET and preinfusion 13 C-NMR sessions, it can be reasonably considered that V ATP was measured under normoglycemia. Given these elements, one can assume that the metabolic fluxes measured in our study were not noticeably affected by glycemic differences.
Validation of VATP as Measured by NMR.
Given the values of CMRglc and V TCA , the corresponding ATP synthesis rate V ATP can be theoretically expressed by establishing stoechiometry between molecules of ATP and reducing equivalents (i) generated by the TCA cycle and oxidative phosphorylation, (ii) generated by glycolysis, and (iii) consumed by the fatty acid pathway. It is well known that the degradation of 1 acetyl-CoA in the TCA cycle leads to the production of 1 ATP, 3 NADH,H ϩ , and 1 FADH 2 , and that glycolysis leads to the production of 2 pyruvate, 2 ATP, and 2 NADH,H ϩ , a posteriori transformed in 2 FADH 2 by crossing the mitochondrial membrane. Also, the conversion of pyruvate into acetyl-CoA in the mitochondrial matrix leads to the production of 2 NADH,H ϩ . Under the hypothesis of all pyruvates produced through glycolysis being converted into acetyl-CoA, the rate of this reaction can be assumed to be equal to CMRglc. Then, the corresponding V ATP can be expressed as:
where (P/O) NADH ). The slightly lower measured value could be explained by a partial uncoupling between the generation of the proton gradient and the use of this gradient for synthesis of ATP from ADP and P i . Possible explanation for partial uncoupling might involve specific uncoupling proteins like the brain-specific UCP4 (40, 41) . However, the theoretical expected value V ATP TH is well within the measurement error of our 31 P-NMR measured V ATP . Therefore, our study does not allow us to conclude on significant uncoupling process in the mammal brain.
To our knowledge, only one previous study was performed in humans to assess the coupling between V TCA and V ATP , measured by 13 C NMR and 31 P NMR, respectively (23) . This study, performed in skeletal muscle, reported the following values: Brain energy metabolism as measured by multimodal imaging: 18 F-FDG was used to quantify CMRglc, 13 C MRS was used to measure VTCA, and 31 P MRS was used to measure VATP. The 3 fluxes are highly consistent, validating 31 ), which demonstrates that the GADPH shunting is dominant in human skeletal muscle. In contrast, the present study gives a cerebral V ATP slightly lower than the theoretical value expected from CMRglc and V TCA ; thus, ruling out the possibility of a contribution of reversible synthesis by GADPH/PGK at the glycolytic level in the brain. Our data would be consistent with the fact that P i is mostly present in neurons while a strong glycolytic component takes place in astrocytes as postulated by Lei et al. (13) . This explanation relies on the hypothesis that lactate (provided by astrocytes through an astrocyte-neuron lactate shuttle) is the major substrate for neuronal oxidative metabolism. Although experimental evidences argue in favor of lactate shuttle having a key role in glutamatergic activation (42, 43) , the significance of this shuttle remains controversial (44, 45) . More importantly, the extent of physiological conditions under which the lactate shuttle dominates direct neuronal glucose uptake remains to be explored. It must be kept in mind that the animal and human metabolic fluxes discussed here were measured under light anesthesia or alpha state (peaceful awakefulness). Further studies will be required to establish that lactate shuttle remains predominant under those physiological conditions.
In conclusion, this study is, to our knowledge, the first report of cerebral CMRglc, V TCA , and V ATP measurements in the same animals under identical physiological conditions. This unique multimodal approach allows a cross-validation of the described 18 F-FDG, 13 C MRS, and 31 P MRS techniques. In particular, this is a direct in vivo validation of the 31 P saturation transfer method as a reliable measurement of the cerebral ATP synthesis rate. Implementation of the 3 methodological approaches brings a unique integrated picture of brain energy metabolism, from glucose phosphorylation to mitochondrial ATP synthesis. This multimodal approach will help to better understand mitochondrial energy defects that are thought to have a key role in neurodegenerative illnesses (46, 47) .
Materials and Methods
The study was conducted on 3 healthy male monkeys (macaca fascicularis, body weight Ϸ5 kg) after they were fasted overnight. All experimental procedures were performed in strict accordance with the recommendations of the European Community (86/609) and the French National Committee (87/ 848) for care and use of laboratory animals. For both PET and NMR sessions, animals were identically anesthetized by a single ketamine-xylazine intramuscular injection followed by an i.v. infusion of propofol (Ϸ200 g/kg/min), intubated, and ventilated. The head was placed in the Sphinx position by using a home made stereotaxic frame with bite-bar and ear rods. During NMR and PET sessions, physiological parameters were monitored and remained stable within normal ranges: 35-37°C for body temperature, 50 -60 mm Hg for noninvasive blood pressure as measured with an air-cuff placed around the arm, 90 -110 min for cardiac frequency, 18 -23 min for respiratory frequency, and 35-40 mm Hg for expired CO 2 saturation.
Experimental Design. Neuroimaging sessions. In this study, the experimental plan aimed at measuring the 3 following metabolic fluxes in a same 2 ϫ 2 ϫ 2 cm 3 cerebral VOI on the group of monkeys: (i) CMRglc using PET acquisitions after i.v. injection of 18 F-FDG (1-h acquisition time, 6 sessions: 2 per monkey); (ii) VTCA using indirect 13 C-NMR spectroscopy during an i.v. infusion of [U-13 C6] glucose (2-h acquisition time, 8 sessions: 2 to 3 per monkey); and (iii) V ATP using 31 P-NMR spectroscopic acquisition by saturation transfer (1.40-h acquisition time, 15 sessions: 4 to 6 per monkey). Given the long acquisition time of NMR measurements, animal welfare motivated our decision not to perform 13 C-NMR and 31 P-NMR during the same session, and to allow at least 2 weeks recovery between 2 subsequent imaging sessions for each monkey.
Each imaging modality has its own sensitivity to the measured metabolic flux: under our experimental conditions, V TCA determination by 13 C NMR was less accurate than CMRglc determination by PET, likely due to the intrinsic low sensitivity of NMR spectroscopy. V ATP determination by 31 P NMR was even less accurate the VTCA determination, mostly due to the high number of measured parameters required to assess V ATP. Our purpose being to compare the 3 fluxes, the number of imaging sessions was empirically set to compensate for sensitivity differences between modalities. This empirical design allowed assessing the 3 fluxes with similar accuracies. VOI positioning and multimodal registration. Proper comparison of the 3 metabolic fluxes requires reproducible positioning of the VOI in the brain for all imaging sessions. For 13 C and 31 P NMR sessions, high-resolution 3D MRI images of the brain (gradient echo sequence, matrix 128 ϫ 128 ϫ 128, resolution 1 ϫ 1 ϫ 1 mm 3 ) were acquired to position the 8-mL VOI. Accurate repositioning was easily achieved for each monkey by using anatomical landmarks on coronal, axial, and sagital images (Fig. 1) , so that NMR acquisitions were performed in comparable VOIs. Since PET provided images of the whole brain, it was necessary to localize the 8-mL VOI on PET images to assess CMRglc from this volume only. We registered 3D reconstructed PET images with 3D MRI by using robust and fully automated rigid registration method (48) . Registration allowed one to accurately localize the NMR detected VOI within PET images and to extract 18 F time activity from this VOI.
CMRglc Measurement by 18 F PET. PET sessions. PET experiments were performed on an ECAT EXACT HRϩ tomograph (Siemens-CTI). After completing a transmission scan with a 68 Ga-68 Ge source for attenuation correction, 24 emission scans (63 slices, 4.5-mm isotropic intrinsic resolution) were collected for 60 min after 18 F-FDG i.v. bolus injection (Ϸ2.5 mCi). To obtain arterial blood function, blood samples were withdrawn every 15 s during the first 2 min of acquisition; then, at 2.30, 3, 5, 7, 10, 15, 20, 30, 40, and 50 min. Arterial blood radioactivity was measured in a cross-calibrated ␥-counter (Cobra Quantum D5003; PerkinElmer). For control of physiological stability, measurements of glycemia, blood pH, pO 2, pCO2, sO2 were performed at the beginning, after 20 min and at the end of the acquisition protocol. Flux quantification. The 8-mL VOI was extracted from the 24 PET images as described above, and the corresponding time activity curve was generated with regional activity calculated for each frame and plotted vs. time. The time activity curve was then fitted by using a 2-tissue compartment model in PMod (PMOD Technologies) (49) , under the hypothesis of irreversible phosphorylation (k 4 ϭ 0). The kinetic constants k1, k2, and k3 describing the exchanges between the pools of plasmatic 18 F-FDG, cytoplasmic 18 F-FDG, and cytoplasmic phosphorylated 18 F-FDG-P were derived from this adjustment. The lumped constant (LC) was fixed to 0.42, according to previous studies (30, 31) . Last, CMRglc was calculated from the values of glycemia, LC, k 1, k2, and k3.
VTCA Measurement by Indirect 13 C NMR. NMR setup and voxel positioning. MR experiments were performed on a whole-body 3 Tesla system (Bruker) equipped with a surface coil placed on top of the head (double-tunable 1 H-31 P, Ø Ϸ 4.5 cm). VTCA sessions started with the acquisition of the 3D MRI and the positioning the VOI. VOI shimming was performed down to Ϸ8 Hz by means of the FASTMAP algorithm (50), for first-and second-order shim coils. Indirect 13 C NMR spectroscopy. Spectra were collected by using a 1 H STEAM sequence (TE/TM/TR ϭ 21/110/2500, 256 transients). Additional localization was achieved by a B1-InSensitive TRain to Obliterate signal (BISTRO) outer volume suppression (OVS) pulse train (51), consisting of 15 modules repeated at increasing RF power levels. Each module was formed by 3 double-band hyperbolic secant pulses selectively saturating slabs outside the 2 ϫ 2 ϫ 2 cm 3 VOI along the X, Z, and Y directions (52) . OVS was combined with VAPOR water suppression (53) . At the beginning of the experiment, a baseline 1 H STEAM spectrum was acquired within the VOI. Then, 1 H STEAM spectra were collected during a 2-step infusion protocol of [U-13 C6] glucose. Infusion started with a 3-min bolus of [U-13 C6] glucose (Ϸ0.3 mL/kg/min, 20% wt/vol), leading quickly to a 3-fold increase in glycemia: blood glucose concentration before bolus infusion was typically 3-5 mmol⅐L Ϫ1 and reached 9 -15 mmol⅐L Ϫ1 after the bolus. Then, a continuous 2-h i.v. infusion of a 2:1 mixture of [U-13 C6] and unlabeled glucose was performed at lower rate (Ϸ0.01 mL/kg/min, 20% wt/vol). This 2-step infusion leads to a stabilization of 13 C fractional enrichment (FE) of plasma glucose Ϸ55 to 60% after 5 min and until the end of infusion (52) . Control measurements of glycemia were performed by using a Onetouch glucose meter (Lifescan). Spectra quantification and VTCA measurement. Measurement of 13 C-glutamate enrichment from the 1 H spectra was based on a previously described method (30, 52) . Briefly, the subtraction of 1 H spectra acquired during the [U- 13 C6] glucose infusion from the baseline 1 H spectrum results in difference spectra exhibiting only labeled nuclei: mainly glutamate C3 and C4 in the brain; 13 C enrichment has 2 effects on the 1 H spectrum: 1 H coupled to 13 C (satellite resonance) appear as a doublet, whereas 1 H bound to 12 C (mother resonance) decrease. Subtracting a 13 C-enriched spectrum from a baseline spectrum provides a difference spectrum where mother resonances exhibit positive intensities (at 2.11 ppm for GluC3 and 2.35 ppm for GluC4), whereas 13 C satellite resonances appear antiphased (at 2.85 and 1.85 ppm for GluC4 and at 1.65 and 2.65 ppm for GluC3); 1 H difference spectra collected during 13 Cglucose infusion are dominated by changes in mother resonances, as shown on Fig. 3A; 1 H difference spectra were quantified by using Java-based MR user interface (jMRUI; see ref. 54) , which performs time domain analysis of freeinduction decays. An original basis set of simulated 1 H difference spectra of glutamate C4 and C3 13 C-enrichment was implemented for the quantitation based on quantum estimation algorithm (QUEST; see ref. 55 ) within jMRUI, by using literature values of resonance frequencies and J-coupling constants (56) . The time courses of C4 and C3 enrichment were first estimated. To assess the value of the TCA cycle flux V TCA, a single compartment model describing the incorporation of 13 C from blood glucose into brain glutamate was implemented on Matlab (The MathWorks Inc.) (5, 33) . The following assumptions were made: (i) glucose transport through the blood-brain barrier follows a reversible Michaelis-Menten kinetic, (ii) the exchange rates V X between glutamate and ␣-ketoglutarate and between oxaloacetate and aspartate are equal, (iii) the rate of the glutamate/glutamine cycling is equal to 0.46 ϫ V TCA (5) . The concentrations of glutamate, glutamine, aspartate, lactate, oxaloacetate, and ␣-ketoglutarate, as well as the glucose transport parameters, were taken from a previous monkey study (52) . 31 P Saturation Transfer NMR. NMR setup and voxel positioning. MR experiments were performed on the previously described 3T system equipped with the same surface coil. VOI positioning and shimming were performed the same way as for V TCA sessions. Theory. Consider the chemical equilibrium between inorganic phosphate Pi and ATP:
VATP Measurement by
where kf and kr are the unidirectional rate constants of ATP synthesis and hydrolysis, respectively. To derive the rate of ATP synthesis V ATP ϭ kf [Pi] , kf is measured by progressively saturating the magnetization of ␥-ATP and observing the effect on the magnetization of the exchange partner P i. Then, kf is derived from the Bloch equations modified for chemical exchange. This method can be applied to ATP synthesis because the lifetime of P i (1/kf) is in the same order as the intrinsic longitudinal relaxation time of P i T1 int . This observation explains why the saturation transfer method is specifically sensitive to ATP synthesis, although P i is involved in several biochemical reactions (12, 13, 17, 18) . However, it must be noted that the P i to ATP conversion catalyzed by the GAPDH/PGK enzymes at the glycolytic level is fast enough to potentially contaminate 31 P-NMR measured Pi attenuation (20 -23) . Saturation Transfer 31 P MRS Experiment. The 31 P spectra were collected from the VOI by using an OVS-localized saturation transfer sequence (57) . A saturation pulse (variable length t sat) was followed with a BISTRO OVS pulse train (total OVS train length t OVS, 310 ms). A 100-s broadpulse was placed immediately after the OVS module for nonselective excitation. The saturation frequency was first set to ␥-ATP frequency (Ϫ7.35 ppm relative to Pi), and spectra were collected for 4 different values of tsat (0.5, 1.0, 1.5, and 2 s) by using a 2.95-s TR and 512 transients for each t sat. Then, control spectra without ␥-ATP saturation were collected. To correct for the RF bleed over effect, control spectra were acquired with a saturation frequency set to ϩ7.35 ppm relative to Pi (control saturation symmetric to ␥-ATP) for the same 4 values of tsat. The total acquisition time including shimming for each tsat was Ϸ100 min. Inversion recovery experiment. The T1 of Pi in the presence of chemical exchange T1 mix was measured by using an inversion recovery sequence: a 180°adiabatic hyperbolic secant pulse (length, 4 ms) set on Pi frequency and a gradient crusher (length, 2 ms) were placed before the OVS module at variable inversion time TI (TI, time between inversion pulse and acquisition). Note that for the TI ϭ 0 experiment, the inversion pulse was placed between the OVS module and the acquisition pulse. Repetition time was fixed to 6.4 s to allow full relaxation of P i magnetization (T1 mix is expected Ϸ2 s at 3 Tesla); 31 P spectra were acquired for 7 values of TI (128 transients). Spectra quantification. All 31 P spectra were zero-filled to 2,048 points and analyzed by using an Advanced Method for Spectral Fitting (AMARES) within jMRUI (54, 58); 13 31 P multiplets were included (24), assuming lorentzian line shapes. Shimming variations between experiments were corrected relative to the estimated linewidth of the dominant resonance PCR. Baseline and 2-order phase corrections were performed. For the saturation transfer experiment, the averaged Pi attenuation ratio was calculated as the average ratio of Pi magnetization on ␥-ATP saturation MS over Pi control magnetization MC for each monkey and each saturation time.
Metabolic modeling and VATP measurement. The time evolution of Pi longitudinal magnetization can be modeled by using the Bloch equation modified for chemical exchange between Pi and ␥-ATP:
where MzPi and Mz␥ATP are the longitudinal magnetizations of Pi and ATP, respectively. MzPi 0 is the fully relaxed longitudinal magnetization of Pi. Pi attenuation MS(tsat)/MC(tsat) depends on the user-fixed sequence parameters (delays t OVS, tsat, and TR, excitation angle ), and on the following unknown parameters: P i relaxation time in presence of chemical exchange T1 mix (59) , unidirectional rate constant of ATP synthesis k f, and Pi intrinsic relaxation time in the absence of chemical exchange T1 int (57) . T1 mix was estimated by the inversion recovery experiment as previously described. The M S(tsat)/MC(tsat) vs. t sat curve was fitted by using a nonlinear least squares algorithm leading to the estimation of the unknown parameters k f and T1 int . Monte Carlo simulation was also performed on this dataset to assess the accuracy on the 2 fitted parameters. The flux of ATP synthesis V ATP was derived from the equation V ATP ϭ kf [Pi] , where the cerebral Pi concentration [Pi] was estimated from the literature (24 -29) .
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